Oxidation of 2'-hydroxychalcone analogues of pyrazole 1 using iodobenzene diacetate in KOHMeOH leads to the formation of cis-3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromanone dimethylacetals 2. The hydrolysis of the dimethylacetals 2 affords either trans-3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromanones 3 and cis-3-hydroxy-2- (1-phenyl-3-aryl-4-pyrazolyl) chromanones 4 depending upon the hydrolytic conditions in good yields. Their 1 H NMR, IR and mass spectra confirmed the structures of the compounds 2, 3 and 4.
Introduction
In recent years, considerable attention has been devoted to the use of hypervalent iodine reagents in organic synthesis. 1 Particularly, hypervalent iodine reagents such as iodobenzene diacetate (IBD), 2 iodobis(trifluoro)acetate (IBTA), 3 [hydroxy(tosyloxy)iodo] benzene (HTIB, Koser's Reagent), 4 IBX 5 and Dess-Martin reagant 6 have been used as versatile oxidizing agents. Previous investigations from our laboratory have shown that IBD, HTIB, etc. find interesting applications in flavonoids. [7] [8] [9] [10] [11] [12] [13] [14] Among the various such applications, one remarkable use of IBD-KOH/MeOH system [15] [16] [17] is the availability of cis-3-hydroxyflavanones dimethylacetals, which can be converted into the corresponding trans-3-hydroxyflavanones and cis-3-hydroxyflavanones depending upon the hydrolytic conditions. cis-3-Hydroxyflavanones cannot be synthesized via conventional methods and pyrazole analogues of cis-and trans-3-hydroxycharmanones of the type 3 and 4 are unknown in literature. Pyrazole 18 and flavanone 19 derivatives are well known for their various biological properties. There has been particular interest in the synthesis of 3-hydroxchromanone derivatives, having both these moieties i.e. flavanone and pyrazole. Therefore, it was considered worthwhile to undertake the oxidation of 2'-hydroxychalcone The probable mechanism for the transformation of 1→ 2 is analogous to our previous work and is outlined in Scheme 2. This mechanism accounts for the cis relationship between C(2)-H and C(3)-H which has been supported by 1 H NMR data. 
Scheme 2
The structures of the dimethylacetals 2, trans-3-hydroxychromanones 3 and cis-3-hydroxychromanones 4 were confirmed by the combined use of 1 H NMR, IR and mass spectra.
In 1 H NMR of dimethylacetals 2, the C(3) proton couple with hydroxy proton split into doublet and C(2) proton has a broad singlet. On shaking with D 2 O, hydroxy proton disappeared and the C(2)-C(3) proton-proton couple together split into doublet of coupling constant 5-6 Hz which agrees with the assigned cis stereochemistry. The 1 H NMR spectra of 3 and 4 enabled differentiation between the two. The coupling constant between the C(2) proton centered at 5.35 ppm and the C(3) proton centered at 4.82 ppm was 5.1 Hz for cis isomer 3 and for trans isomer 4 was 12.6 Hz. + .
+ .
Scheme 3
The mass spectral fragmentation pattern for 3 relative to 4 did not show significant mutual differences. An important fragmentation was the retro-Diels-Alder cleavage, which has been described by Buset and Scheline 20 in some 3-hydroxyflavanones. Similarly the rDA pathway is also followed by compound 2.
Conclusions
Finally, it is clear from the results of the present study that the I(III) mediated approach offers an easy and simple method for synthesizing new trans-and cis-3-hydroxychromanones 3 and 4 as well as their dimethylacetals 2.
Experimental Section
General Procedures. Melting points were determined in open capillaries with electrical melting point apparatus and are uncorrected. The ΙR spectra were obtained with a Buck Scientific ΙR M-500 spectrophotometer. The 1 H NMR spectra were recorded on a Bruker (300 MHz) spectrometer using tetramethylsilane as an internal standard. Elemental analysis (CHN) and mass spectra were performed by RSIC, Central Drug Research Institute, Lucknow, India. Elemental analyses were recorded on Elementar Vario EL III Carlo Erba 1108 analyzer. All the new compounds gave satisfactory analytical results (with in ±0.4 of the theoretical values). 1-(2-hydroxyphenyl)-3-(1-phenyl-3-aryl-4-pyrazolyl)-2-propen-1-ones (1) were obtained by the condensation of 2'-hydroxyacetophenone with 1-phenyl-3-arylpyrazole-4-carboxaldehydes in KOH-MeOH.
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General procedure for preparation of cis-3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromanone dimethylacetals (2). A solution of 1-(2-hydroxyphenyl)-3-(1-phenyl-3-aryl-4-pyrazolyl)-2-propen-1-ones (1) (0.01 mol) in methanol (50 ml) was added dropwise to a stirred solution of potassium hydroxide (0.03 mol) in 30 ml of methanol over a period of 15 min at 5-10 ˚C. The resulting yellow-brown solution was stirred for 10 min and then was added iodobenzene diacetate (0.011 mol) in four portions during 10 min. The reaction mixture was stirred over night at room temperature. Then most of the methanol was removed in vacuo and to the residue was added 100 ml of water. A yellow solid was filtered, washed with cold water and dried. The crude product was crystallized with methanol. The physical, analytical and spectral data of new cis-3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromanone dimethylacetals (2) are given below. cis-3-Hydroxy-2-(1, 3-diphenyl-4-pyrazolyl) chromanone dimethylacetal (2a Hydroxy-2-[(1-phenyl-3-(p-nitrophenyl)-4-pyrazolyl) General procedure for preparation of cis-3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromanones (4). A mixture of dimetylacetals 2 (0.005 mol) and 40 ml of 50% acetic acid was stirred at 60-70 ˚C for 6 hours. The resulting solution after cooling was mixed with 40 ml of water and the solid was filtered, washed with cold water and dried. The crude product was crystallized with methanol. 
